Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore

Warburg Pincus, ChrysCapital, TPG, Blackstone, EQT, Mankind Pharma, and Dr Reddy's Laboratories are competing to acquire BSV Group, a biopharma firm specializing in women's health and critical care products, indicating a trend of consolidation in the domestic pharma sector. Mankind, Dr. Reddy’s, and Blackstone have evaluated BSV at different times, including before Advent's acquisition.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rn9v0ef
via IFTTT